共 21 条
Adverse Events in an Integrated Home-Based Treatment Program for MDR-TB and HIV in KwaZulu-Natal, South Africa
被引:24
作者:
Brust, James C. M.
[1
,2
]
Shah, N. Sarita
[1
,2
]
van der Merwe, Theo L.
[3
,4
]
Bamber, Sheila
[3
,4
,5
]
Ning, Yuming
[1
,2
]
Heo, Moonseong
[2
,6
]
Moll, Anthony P.
[3
,4
]
Loveday, Marian
[7
,8
]
Lalloo, Umesh G.
[8
]
Friedland, Gerald H.
[9
,10
]
Gandhi, Neel R.
[1
,2
,11
]
机构:
[1] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Philanjalo, Tugela Ferry, South Africa
[4] Church Scotland Hosp, Tugela Ferry, South Africa
[5] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa
[6] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[7] MRC, Hlth Syst Res Unit, Cape Town, South Africa
[8] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med, Durban, South Africa
[9] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
[10] Yale Univ, Sch Med, Dept Epidemiol, New Haven, CT 06510 USA
[11] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
基金:
美国国家卫生研究院;
关键词:
HIV;
multidrug-resistant tuberculosis;
side effects;
adverse events;
resource-limited settings;
MULTIDRUG-RESISTANT TUBERCULOSIS;
COMMUNITY-BASED THERAPY;
HYPOTHYROIDISM;
D O I:
10.1097/QAI.0b013e31828175ed
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Most patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are HIV-infected, but the safety and tolerability of cotreatment are unknown. The authors reviewed all adverse events (AEs) for patients with MDR-TB in a home-based treatment program in rural KwaZulu-Natal. Of 91 MDR-TB patients, 74 (81%) were HIV-positive and receiving antiretroviral therapy. AEs were common, but most were mild and did not require therapy modification. The most common severe AEs were hypothyroidism (36%) and psychosis (5%). Patients receiving concurrent antiretroviral therapy did not experience AEs more frequently than those on MDR-TB therapy alone. Concurrent treatment for MDR-TB/HIV can be safely administered in a home-based care setting.
引用
收藏
页码:436 / 440
页数:5
相关论文